Global and United States Recombinant Coagulation Factor Concentrate Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.

Market Analysis and Insights: Global and United States Recombinant Coagulation Factor Concentrate Market

This report focuses on global and United States Recombinant Coagulation Factor Concentrate market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Recombinant Coagulation Factor Concentrate market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Dose, 250 IU accounting for % of the Recombinant Coagulation Factor Concentrate global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hopistial was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Recombinant Coagulation Factor Concentrate market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Recombinant Coagulation Factor Concentrate Scope and Market Size
Recombinant Coagulation Factor Concentrate market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Recombinant Coagulation Factor Concentrate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Recombinant Coagulation Factor Concentrate market size by players, by Dose and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Dose
    250 IU
    500 IU
    1000 IU
    2000 IU

Segment by Application
    Hopistial
    Clinic
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Bayer
    Alprolix
    Benefix
    Idelvion
    Lxinity
    Rebinyn
    Rixubis
    CSL
    Baxalta
    Sanofi
    Biogen
    Pfizer
    Novo Disk
    Baxter
    Wyeth
    北京天坛生物制品股份有限公司
    上海莱士
    泰邦生物
    华兰生物
    绿十字（中国）生物制品有限公司

 1 Study Coverage
    1.1 Recombinant Coagulation Factor Concentrate Product Introduction
    1.2 Global Recombinant Coagulation Factor Concentrate Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Recombinant Coagulation Factor Concentrate Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Recombinant Coagulation Factor Concentrate Sales in Volume for the Year 2017-2028
    1.3 United States Recombinant Coagulation Factor Concentrate Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Recombinant Coagulation Factor Concentrate Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Recombinant Coagulation Factor Concentrate Sales in Volume for the Year 2017-2028
    1.4 Recombinant Coagulation Factor Concentrate Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Recombinant Coagulation Factor Concentrate in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Recombinant Coagulation Factor Concentrate Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Recombinant Coagulation Factor Concentrate Market Dynamics
        1.5.1 Recombinant Coagulation Factor Concentrate Industry Trends
        1.5.2 Recombinant Coagulation Factor Concentrate Market Drivers
        1.5.3 Recombinant Coagulation Factor Concentrate Market Challenges
        1.5.4 Recombinant Coagulation Factor Concentrate Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Dose
    2.1 Recombinant Coagulation Factor Concentrate Market Segment by Dose
        2.1.1 250 IU
        2.1.2 500 IU
        2.1.3 1000 IU
        2.1.4 2000 IU
    2.2 Global Recombinant Coagulation Factor Concentrate Market Size by Dose
        2.2.1 Global Recombinant Coagulation Factor Concentrate Sales in Value, by Dose (2017, 2022 & 2028)
        2.2.2 Global Recombinant Coagulation Factor Concentrate Sales in Volume, by Dose (2017, 2022 & 2028)
        2.2.3 Global Recombinant Coagulation Factor Concentrate Average Selling Price (ASP) by Dose (2017, 2022 & 2028)
    2.3 United States Recombinant Coagulation Factor Concentrate Market Size by Dose
        2.3.1 United States Recombinant Coagulation Factor Concentrate Sales in Value, by Dose (2017, 2022 & 2028)
        2.3.2 United States Recombinant Coagulation Factor Concentrate Sales in Volume, by Dose (2017, 2022 & 2028)
        2.3.3 United States Recombinant Coagulation Factor Concentrate Average Selling Price (ASP) by Dose (2017, 2022 & 2028)

 3 Market by Application
    3.1 Recombinant Coagulation Factor Concentrate Market Segment by Application
        3.1.1 Hopistial
        3.1.2 Clinic
        3.1.3 Others
    3.2 Global Recombinant Coagulation Factor Concentrate Market Size by Application
        3.2.1 Global Recombinant Coagulation Factor Concentrate Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Recombinant Coagulation Factor Concentrate Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Recombinant Coagulation Factor Concentrate Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Recombinant Coagulation Factor Concentrate Market Size by Application
        3.3.1 United States Recombinant Coagulation Factor Concentrate Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Recombinant Coagulation Factor Concentrate Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Recombinant Coagulation Factor Concentrate Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Recombinant Coagulation Factor Concentrate Competitor Landscape by Company
    4.1 Global Recombinant Coagulation Factor Concentrate Market Size by Company
        4.1.1 Top Global Recombinant Coagulation Factor Concentrate Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Recombinant Coagulation Factor Concentrate Revenue by Manufacturer (2017-2022)
        4.1.3 Global Recombinant Coagulation Factor Concentrate Sales by Manufacturer (2017-2022)
        4.1.4 Global Recombinant Coagulation Factor Concentrate Price by Manufacturer (2017-2022)
    4.2 Global Recombinant Coagulation Factor Concentrate Concentration Ratio (CR)
        4.2.1 Recombinant Coagulation Factor Concentrate Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Recombinant Coagulation Factor Concentrate in 2021
        4.2.3 Global Recombinant Coagulation Factor Concentrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Recombinant Coagulation Factor Concentrate Manufacturing Base Distribution, Product Type
        4.3.1 Global Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Recombinant Coagulation Factor Concentrate Product Type
        4.3.3 Date of International Manufacturers Enter into Recombinant Coagulation Factor Concentrate Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Recombinant Coagulation Factor Concentrate Market Size by Company
        4.5.1 Top Recombinant Coagulation Factor Concentrate Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Recombinant Coagulation Factor Concentrate Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Recombinant Coagulation Factor Concentrate Sales by Players (2020, 2021 & 2022)

 5 Global Recombinant Coagulation Factor Concentrate Market Size by Region
    5.1 Global Recombinant Coagulation Factor Concentrate Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Recombinant Coagulation Factor Concentrate Market Size in Volume by Region (2017-2028)
        5.2.1 Global Recombinant Coagulation Factor Concentrate Sales in Volume by Region: 2017-2022
        5.2.2 Global Recombinant Coagulation Factor Concentrate Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Recombinant Coagulation Factor Concentrate Market Size in Value by Region (2017-2028)
        5.3.1 Global Recombinant Coagulation Factor Concentrate Sales in Value by Region: 2017-2022
        5.3.2 Global Recombinant Coagulation Factor Concentrate Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Recombinant Coagulation Factor Concentrate Market Size YoY Growth 2017-2028
        6.1.2 North America Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Recombinant Coagulation Factor Concentrate Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Recombinant Coagulation Factor Concentrate Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Recombinant Coagulation Factor Concentrate Market Size YoY Growth 2017-2028
        6.3.2 Europe Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Recombinant Coagulation Factor Concentrate Market Size YoY Growth 2017-2028
        6.4.2 Latin America Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Recombinant Coagulation Factor Concentrate Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Corporation Information
        7.1.2 Bayer Description and Business Overview
        7.1.3 Bayer Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Bayer Recombinant Coagulation Factor Concentrate Products Offered
        7.1.5 Bayer Recent Development
    7.2 Alprolix
        7.2.1 Alprolix Corporation Information
        7.2.2 Alprolix Description and Business Overview
        7.2.3 Alprolix Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Alprolix Recombinant Coagulation Factor Concentrate Products Offered
        7.2.5 Alprolix Recent Development
    7.3 Benefix
        7.3.1 Benefix Corporation Information
        7.3.2 Benefix Description and Business Overview
        7.3.3 Benefix Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Benefix Recombinant Coagulation Factor Concentrate Products Offered
        7.3.5 Benefix Recent Development
    7.4 Idelvion
        7.4.1 Idelvion Corporation Information
        7.4.2 Idelvion Description and Business Overview
        7.4.3 Idelvion Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Idelvion Recombinant Coagulation Factor Concentrate Products Offered
        7.4.5 Idelvion Recent Development
    7.5 Lxinity
        7.5.1 Lxinity Corporation Information
        7.5.2 Lxinity Description and Business Overview
        7.5.3 Lxinity Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Lxinity Recombinant Coagulation Factor Concentrate Products Offered
        7.5.5 Lxinity Recent Development
    7.6 Rebinyn
        7.6.1 Rebinyn Corporation Information
        7.6.2 Rebinyn Description and Business Overview
        7.6.3 Rebinyn Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Rebinyn Recombinant Coagulation Factor Concentrate Products Offered
        7.6.5 Rebinyn Recent Development
    7.7 Rixubis
        7.7.1 Rixubis Corporation Information
        7.7.2 Rixubis Description and Business Overview
        7.7.3 Rixubis Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Rixubis Recombinant Coagulation Factor Concentrate Products Offered
        7.7.5 Rixubis Recent Development
    7.8 CSL
        7.8.1 CSL Corporation Information
        7.8.2 CSL Description and Business Overview
        7.8.3 CSL Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 CSL Recombinant Coagulation Factor Concentrate Products Offered
        7.8.5 CSL Recent Development
    7.9 Baxalta
        7.9.1 Baxalta Corporation Information
        7.9.2 Baxalta Description and Business Overview
        7.9.3 Baxalta Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Baxalta Recombinant Coagulation Factor Concentrate Products Offered
        7.9.5 Baxalta Recent Development
    7.10 Sanofi
        7.10.1 Sanofi Corporation Information
        7.10.2 Sanofi Description and Business Overview
        7.10.3 Sanofi Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Sanofi Recombinant Coagulation Factor Concentrate Products Offered
        7.10.5 Sanofi Recent Development
    7.11 Biogen
        7.11.1 Biogen Corporation Information
        7.11.2 Biogen Description and Business Overview
        7.11.3 Biogen Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Biogen Recombinant Coagulation Factor Concentrate Products Offered
        7.11.5 Biogen Recent Development
    7.12 Pfizer
        7.12.1 Pfizer Corporation Information
        7.12.2 Pfizer Description and Business Overview
        7.12.3 Pfizer Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Pfizer Products Offered
        7.12.5 Pfizer Recent Development
    7.13 Novo Disk
        7.13.1 Novo Disk Corporation Information
        7.13.2 Novo Disk Description and Business Overview
        7.13.3 Novo Disk Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 Novo Disk Products Offered
        7.13.5 Novo Disk Recent Development
    7.14 Baxter
        7.14.1 Baxter Corporation Information
        7.14.2 Baxter Description and Business Overview
        7.14.3 Baxter Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 Baxter Products Offered
        7.14.5 Baxter Recent Development
    7.15 Wyeth
        7.15.1 Wyeth Corporation Information
        7.15.2 Wyeth Description and Business Overview
        7.15.3 Wyeth Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.15.4 Wyeth Products Offered
        7.15.5 Wyeth Recent Development
    7.16 北京天坛生物制品股份有限公司
        7.16.1 北京天坛生物制品股份有限公司 Corporation Information
        7.16.2 北京天坛生物制品股份有限公司 Description and Business Overview
        7.16.3 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.16.4 北京天坛生物制品股份有限公司 Products Offered
        7.16.5 北京天坛生物制品股份有限公司 Recent Development
    7.17 上海莱士
        7.17.1 上海莱士 Corporation Information
        7.17.2 上海莱士 Description and Business Overview
        7.17.3 上海莱士 Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.17.4 上海莱士 Products Offered
        7.17.5 上海莱士 Recent Development
    7.18 泰邦生物
        7.18.1 泰邦生物 Corporation Information
        7.18.2 泰邦生物 Description and Business Overview
        7.18.3 泰邦生物 Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.18.4 泰邦生物 Products Offered
        7.18.5 泰邦生物 Recent Development
    7.19 华兰生物
        7.19.1 华兰生物 Corporation Information
        7.19.2 华兰生物 Description and Business Overview
        7.19.3 华兰生物 Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.19.4 华兰生物 Products Offered
        7.19.5 华兰生物 Recent Development
    7.20 绿十字（中国）生物制品有限公司
        7.20.1 绿十字（中国）生物制品有限公司 Corporation Information
        7.20.2 绿十字（中国）生物制品有限公司 Description and Business Overview
        7.20.3 绿十字（中国）生物制品有限公司 Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2017-2022)
        7.20.4 绿十字（中国）生物制品有限公司 Products Offered
        7.20.5 绿十字（中国）生物制品有限公司 Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Recombinant Coagulation Factor Concentrate Industry Chain Analysis
    8.2 Recombinant Coagulation Factor Concentrate Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Recombinant Coagulation Factor Concentrate Distributors
    8.3 Recombinant Coagulation Factor Concentrate Production Mode & Process
    8.4 Recombinant Coagulation Factor Concentrate Sales and Marketing
        8.4.1 Recombinant Coagulation Factor Concentrate Sales Channels
        8.4.2 Recombinant Coagulation Factor Concentrate Distributors
    8.5 Recombinant Coagulation Factor Concentrate Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Recombinant Coagulation Factor Concentrate CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Recombinant Coagulation Factor Concentrate Market Trends
    Table 3. Recombinant Coagulation Factor Concentrate Market Drivers
    Table 4. Recombinant Coagulation Factor Concentrate Market Challenges
    Table 5. Recombinant Coagulation Factor Concentrate Market Restraints
    Table 6. Global Recombinant Coagulation Factor Concentrate Sales by Dose: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Recombinant Coagulation Factor Concentrate Sales by Dose: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Recombinant Coagulation Factor Concentrate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Recombinant Coagulation Factor Concentrate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Recombinant Coagulation Factor Concentrate Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Recombinant Coagulation Factor Concentrate Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Recombinant Coagulation Factor Concentrate Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Recombinant Coagulation Factor Concentrate Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Recombinant Coagulation Factor Concentrate Sales Share by Manufacturer, 2017-2022
    Table 15. Global Recombinant Coagulation Factor Concentrate Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Recombinant Coagulation Factor Concentrate Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Recombinant Coagulation Factor Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Coagulation Factor Concentrate as of 2021)
    Table 18. Top Players of Recombinant Coagulation Factor Concentrate in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Recombinant Coagulation Factor Concentrate Product Type
    Table 20. Date of International Manufacturers Enter into Recombinant Coagulation Factor Concentrate Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Recombinant Coagulation Factor Concentrate Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Recombinant Coagulation Factor Concentrate Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Recombinant Coagulation Factor Concentrate Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Recombinant Coagulation Factor Concentrate Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Recombinant Coagulation Factor Concentrate Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Recombinant Coagulation Factor Concentrate Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Recombinant Coagulation Factor Concentrate Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Recombinant Coagulation Factor Concentrate Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Recombinant Coagulation Factor Concentrate Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Recombinant Coagulation Factor Concentrate Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Recombinant Coagulation Factor Concentrate Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Recombinant Coagulation Factor Concentrate Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Recombinant Coagulation Factor Concentrate Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Recombinant Coagulation Factor Concentrate Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Recombinant Coagulation Factor Concentrate Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Recombinant Coagulation Factor Concentrate Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bayer Corporation Information
    Table 43. Bayer Description and Business Overview
    Table 44. Bayer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Bayer Recombinant Coagulation Factor Concentrate Product
    Table 46. Bayer Recent Development
    Table 47. Alprolix Corporation Information
    Table 48. Alprolix Description and Business Overview
    Table 49. Alprolix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Alprolix Product
    Table 51. Alprolix Recent Development
    Table 52. Benefix Corporation Information
    Table 53. Benefix Description and Business Overview
    Table 54. Benefix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Benefix Product
    Table 56. Benefix Recent Development
    Table 57. Idelvion Corporation Information
    Table 58. Idelvion Description and Business Overview
    Table 59. Idelvion Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Idelvion Product
    Table 61. Idelvion Recent Development
    Table 62. Lxinity Corporation Information
    Table 63. Lxinity Description and Business Overview
    Table 64. Lxinity Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Lxinity Product
    Table 66. Lxinity Recent Development
    Table 67. Rebinyn Corporation Information
    Table 68. Rebinyn Description and Business Overview
    Table 69. Rebinyn Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Rebinyn Product
    Table 71. Rebinyn Recent Development
    Table 72. Rixubis Corporation Information
    Table 73. Rixubis Description and Business Overview
    Table 74. Rixubis Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Rixubis Product
    Table 76. Rixubis Recent Development
    Table 77. CSL Corporation Information
    Table 78. CSL Description and Business Overview
    Table 79. CSL Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. CSL Product
    Table 81. CSL Recent Development
    Table 82. Baxalta Corporation Information
    Table 83. Baxalta Description and Business Overview
    Table 84. Baxalta Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Baxalta Product
    Table 86. Baxalta Recent Development
    Table 87. Sanofi Corporation Information
    Table 88. Sanofi Description and Business Overview
    Table 89. Sanofi Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Sanofi Product
    Table 91. Sanofi Recent Development
    Table 92. Biogen Corporation Information
    Table 93. Biogen Description and Business Overview
    Table 94. Biogen Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Biogen Product
    Table 96. Biogen Recent Development
    Table 97. Pfizer Corporation Information
    Table 98. Pfizer Description and Business Overview
    Table 99. Pfizer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Pfizer Product
    Table 101. Pfizer Recent Development
    Table 102. Novo Disk Corporation Information
    Table 103. Novo Disk Description and Business Overview
    Table 104. Novo Disk Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. Novo Disk Product
    Table 106. Novo Disk Recent Development
    Table 107. Baxter Corporation Information
    Table 108. Baxter Description and Business Overview
    Table 109. Baxter Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Baxter Product
    Table 111. Baxter Recent Development
    Table 112. Wyeth Corporation Information
    Table 113. Wyeth Description and Business Overview
    Table 114. Wyeth Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 115. Wyeth Product
    Table 116. Wyeth Recent Development
    Table 117. 北京天坛生物制品股份有限公司 Corporation Information
    Table 118. 北京天坛生物制品股份有限公司 Description and Business Overview
    Table 119. 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 120. 北京天坛生物制品股份有限公司 Product
    Table 121. 北京天坛生物制品股份有限公司 Recent Development
    Table 122. 上海莱士 Corporation Information
    Table 123. 上海莱士 Description and Business Overview
    Table 124. 上海莱士 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 125. 上海莱士 Product
    Table 126. 上海莱士 Recent Development
    Table 127. 泰邦生物 Corporation Information
    Table 128. 泰邦生物 Description and Business Overview
    Table 129. 泰邦生物 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 130. 泰邦生物 Product
    Table 131. 泰邦生物 Recent Development
    Table 132. 华兰生物 Corporation Information
    Table 133. 华兰生物 Description and Business Overview
    Table 134. 华兰生物 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 135. 华兰生物 Product
    Table 136. 华兰生物 Recent Development
    Table 137. 绿十字（中国）生物制品有限公司 Corporation Information
    Table 138. 绿十字（中国）生物制品有限公司 Description and Business Overview
    Table 139. 绿十字（中国）生物制品有限公司 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 140. 绿十字（中国）生物制品有限公司 Product
    Table 141. 绿十字（中国）生物制品有限公司 Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Recombinant Coagulation Factor Concentrate Customers List
    Table 145. Recombinant Coagulation Factor Concentrate Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Coagulation Factor Concentrate Product Picture
    Figure 2. Global Recombinant Coagulation Factor Concentrate Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Recombinant Coagulation Factor Concentrate Market Size 2017-2028 (US$ Million)
    Figure 4. Global Recombinant Coagulation Factor Concentrate Sales 2017-2028 (K Units)
    Figure 5. United States Recombinant Coagulation Factor Concentrate Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Recombinant Coagulation Factor Concentrate Market Size 2017-2028 (US$ Million)
    Figure 7. United States Recombinant Coagulation Factor Concentrate Sales 2017-2028 (K Units)
    Figure 8. United States Recombinant Coagulation Factor Concentrate Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Recombinant Coagulation Factor Concentrate Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Recombinant Coagulation Factor Concentrate Report Years Considered
    Figure 11. Product Picture of 250 IU
    Figure 12. Product Picture of 500 IU
    Figure 13. Product Picture of 1000 IU
    Figure 14. Product Picture of 2000 IU
    Figure 15. Global Recombinant Coagulation Factor Concentrate Market Share by Dose in 2022 & 2028
    Figure 16. Global Recombinant Coagulation Factor Concentrate Sales in Value by Dose (2017-2028) & (US$ Million)
    Figure 17. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Value by Dose (2017-2028)
    Figure 18. Global Recombinant Coagulation Factor Concentrate Sales by Dose (2017-2028) & (K Units)
    Figure 19. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Dose (2017-2028)
    Figure 20. Global Recombinant Coagulation Factor Concentrate Price by Dose (2017-2028) & (US$/Unit)
    Figure 21. United States Recombinant Coagulation Factor Concentrate Market Share by Dose in 2022 & 2028
    Figure 22. United States Recombinant Coagulation Factor Concentrate Sales in Value by Dose (2017-2028) & (US$ Million)
    Figure 23. United States Recombinant Coagulation Factor Concentrate Sales Market Share in Value by Dose (2017-2028)
    Figure 24. United States Recombinant Coagulation Factor Concentrate Sales by Dose (2017-2028) & (K Units)
    Figure 25. United States Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Dose (2017-2028)
    Figure 26. United States Recombinant Coagulation Factor Concentrate Price by Dose (2017-2028) & (US$/Unit)
    Figure 27. Product Picture of Hopistial
    Figure 28. Product Picture of Clinic
    Figure 29. Product Picture of Others
    Figure 30. Global Recombinant Coagulation Factor Concentrate Market Share by Application in 2022 & 2028
    Figure 31. Global Recombinant Coagulation Factor Concentrate Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Recombinant Coagulation Factor Concentrate Sales by Application (2017-2028) & (K Units)
    Figure 34. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Recombinant Coagulation Factor Concentrate Price by Application (2017-2028) & (US$/Unit)
    Figure 36. United States Recombinant Coagulation Factor Concentrate Market Share by Application in 2022 & 2028
    Figure 37. United States Recombinant Coagulation Factor Concentrate Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Recombinant Coagulation Factor Concentrate Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Recombinant Coagulation Factor Concentrate Sales by Application (2017-2028) & (K Units)
    Figure 40. United States Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Recombinant Coagulation Factor Concentrate Price by Application (2017-2028) & (US$/Unit)
    Figure 42. North America Recombinant Coagulation Factor Concentrate Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. United States Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Recombinant Coagulation Factor Concentrate Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. Europe Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Recombinant Coagulation Factor Concentrate Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 54. Asia-Pacific Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. China Taiwan Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Recombinant Coagulation Factor Concentrate Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Recombinant Coagulation Factor Concentrate Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Recombinant Coagulation Factor Concentrate Value Chain
    Figure 75. Recombinant Coagulation Factor Concentrate Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed

Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.

Market Analysis and Insights: Global and United States Recombinant Coagulation Factor Concentrate Market

This report focuses on global and United States Recombinant Coagulation Factor Concentrate market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Recombinant Coagulation Factor Concentrate market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Dose, 250 IU accounting for % of the Recombinant Coagulation Factor Concentrate global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hopistial was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Recombinant Coagulation Factor Concentrate market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Recombinant Coagulation Factor Concentrate Scope and Market Size
Recombinant Coagulation Factor Concentrate market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Recombinant Coagulation Factor Concentrate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Recombinant Coagulation Factor Concentrate market size by players, by Dose and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Dose
    250 IU
    500 IU
    1000 IU
    2000 IU

Segment by Application
    Hopistial
    Clinic
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Bayer
    Alprolix
    Benefix
    Idelvion
    Lxinity
    Rebinyn
    Rixubis
    CSL
    Baxalta
    Sanofi
    Biogen
    Pfizer
    Novo Disk
    Baxter
    Wyeth
    北京天坛生物制品股份有限公司
    上海莱士
    泰邦生物
    华兰生物
    绿十字（中国）生物制品有限公司